OGEN Latest Press Releases

-- February 9, 2026 --

Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy Globe Newswire 8:30 AM

-- February 3, 2026 --

Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program Globe Newswire 8:30 AM

-- February 2, 2026 --

Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care Globe Newswire 8:30 AM

-- January 14, 2026 --

Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico Globe Newswire 8:30 AM

-- November 12, 2025 --

Oragenics Q3 2025 Shareholder Update Business Wire 8:30 AM

-- October 21, 2025 --

Oragenics Regains Full NYSE American Compliance, Company Resolves Stockholder Equity Deficiency Business Wire 8:00 AM

-- October 7, 2025 --

Oragenics Announces Strategic Partnership with Receptor.AI to Accelerate Pipeline Development Business Wire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software